9-13 In two of the trials, there was a significant association between the use of a synthetic GLP-1/GIP agonist and worse eye-related outcomes
Patients interested in this kind of weight loss treatment should be aware that there are also severe medical issues such as gallbladder issues, heart disease, and kidney damage linked to this drug, making regular monitoring by healthcare providers highly important for anyone taking it long term
J Neuroinflammation 22(1):34
ROS stimulates the activity of many physiological components, including mitogen-activated protein kinases (MAPK), tyrosine kinases, Rho kinases, and transcription factors (NF-kB, AP-1, and HIF-1) and increased concentration of intracellular free Ca 2+ also inactivates the protein tyrosine phosphatases (PTP)
In those cases, tirzepatide (a dual GIP/GLP-1 agonist) often produces better results
As with the other deals, its not clear how much the price drop will be felt by consumers